Which of the following is the first non-factor prophylactic bypassing agent that was recently approved for haemophilia A patients with and without inhibitors?
Which of the following is the first non-factor prophylactic bypassing agent that was recently approved for haemophilia A patients with and without inhibitors? Correct Answer Emicizumab
Emicizumab is the first non-factor prophylactic bypassing agent that was recently approved for haemophilia A patients with and without inhibitors. Emicizumab (hemlibra) is a bispecific antibody that acts as a FVIIIa – mimetic with procoagulant activity.
মোঃ আরিফুল ইসলাম
Feb 20, 2025